The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical E...

por Waters, J S, O'Brien, M E R
Publicado 2002

Treatment options for small cell lung cancer – do we have more choice?

por Puglisi, M, Dolly, S, Faria, A, Myerson, J S, Popat, S, O'Brien, M E R
Publicado 2010

Time and chemotherapy treatment trends in the treatment of elderly patients (age ⩾70 years) with small cell lung cancer

por Yau, T, Ashley, S, Popat, S, Norton, A, Matakidou, A, Coward, J, O'Brien, M E R
Publicado 2006

Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy

por Barrett-Lee, P J, Bailey, N P, O'Brien, M E R, Wager, E
Publicado 2000

Serum p53 antibodies: predictors of survival in small-cell lung cancer?

por Murray, P V, Soussi, T, O'Brien, M E R, Smith, I E, Brossault, S, Norton, A, Ashley, S, Tavassoli, M
Publicado 2000

Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial

por Boer, R H de, Smith, I E, Pastorino, U, O'Brien, M E R, Ramage, F, Ashley, S, Goldstraw, P
Publicado 1999

Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

por Ross, P J, Ashley, S, Norton, A, Priest, K, Waters, J S, Eisen, T, Smith, I E, O'Brien, M E R
Publicado 2004

Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients

por O'Brien, M E R, Borthwick, A, Rigg, A, Leary, A, Assersohn, L, Last, K, Tan, S, Milan, S, Tait, D, Smith, I E
Publicado 2006

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19

por Cui, W., Milner-Watts, C., Saith, S., Bhosle, J., Minchom, A.R., Davidson, M., Page, S., Locke, I., Yousaf, N., Popat, S., O'Brien, M.E.R.
Publicado 2021

An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B(12) and folic acid supplementation in the treatment of lung cancer with plasma homocysteine bl...

por Minchom, A R, Saksornchai, K, Bhosle, J, Gunapala, R, Puglisi, M, Lu, S K, Nimako, K, Coward, J, Yu, K C, Bordi, P, Popat, S, O'Brien, M E R
Publicado 2014

Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma

por Mendes, R, O'Brien, M E R, Mitra, A, Norton, A, Gregory, R K, Padhani, A R, Bromelow, K V, Winkley, A R, Ashley, S, Smith, I E, Souberbielle, B E
Publicado 2002

A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma

por O’Brien, M E R, Saini, A, Smith, I E, Webb, A, Gregory, K, Mendes, R, Ryan, C, Priest, K, Bromelow, K V, Palmer, R D, Tuckwell, N, Kennard, D A, Souberbielle, B E
Publicado 2000